Global New Generation Implants Market Research Report 2023

Publication ID:

PB503243254

Publication Date:

March 7, 2023

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Implant is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis such as a crown, bridge, denture, facial prosthesis or to act as an orthodontic anchor.
Highlights
The global New Generation Implants market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for New Generation Implants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for New Generation Implants is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of New Generation Implants include Abbott Laboratories, Arthrex, Biotronik SE and Co. KG, BOSTON SCIENTIFIC CORPORATION, BD, DANAHER CORPORATION, DENTSPLY SIRNA Inc., Edwards Lifesciences and Globus Medical Inc., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for New Generation Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Generation Implants.
The New Generation Implants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global New Generation Implants market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Generation Implants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott Laboratories
Arthrex
Biotronik SE and Co. KG
BOSTON SCIENTIFIC CORPORATION
BD
DANAHER CORPORATION
DENTSPLY SIRNA Inc.
Edwards Lifesciences
Globus Medical Inc.
Integer Holdings Corporation
Integra LifeSciences Corporation
Institut Straumann AG
LifeNet Health, Inc.
LivaNova PLC
Novartis International AG
Segment by Type
Metals and Metal Alloys
Ceramics
Polymers
Biologics
Others
Segment by Application
Orthopedic Implants
Cardiovascular Implants
Ocular Implants
Dental Implants
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of New Generation Implants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of New Generation Implants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 New Generation Implants Market Overview
1.1 Product Overview and Scope of New Generation Implants
1.2 New Generation Implants Segment by Type
1.2.1 Global New Generation Implants Market Value Comparison by Type (2023-2029)
1.2.2 Metals and Metal Alloys
1.2.3 Ceramics
1.2.4 Polymers
1.2.5 Biologics
1.2.6 Others
1.3 New Generation Implants Segment by Application
1.3.1 Global New Generation Implants Market Value by Application: (2023-2029)
1.3.2 Orthopedic Implants
1.3.3 Cardiovascular Implants
1.3.4 Ocular Implants
1.3.5 Dental Implants
1.4 Global New Generation Implants Market Size Estimates and Forecasts
1.4.1 Global New Generation Implants Revenue 2018-2029
1.4.2 Global New Generation Implants Sales 2018-2029
1.4.3 Global New Generation Implants Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 New Generation Implants Market Competition by Manufacturers
2.1 Global New Generation Implants Sales Market Share by Manufacturers (2018-2023)
2.2 Global New Generation Implants Revenue Market Share by Manufacturers (2018-2023)
2.3 Global New Generation Implants Average Price by Manufacturers (2018-2023)
2.4 Global New Generation Implants Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of New Generation Implants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of New Generation Implants, Product Type & Application
2.7 New Generation Implants Market Competitive Situation and Trends
2.7.1 New Generation Implants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest New Generation Implants Players Market Share by Revenue
2.7.3 Global New Generation Implants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 New Generation Implants Retrospective Market Scenario by Region
3.1 Global New Generation Implants Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global New Generation Implants Global New Generation Implants Sales by Region: 2018-2029
3.2.1 Global New Generation Implants Sales by Region: 2018-2023
3.2.2 Global New Generation Implants Sales by Region: 2024-2029
3.3 Global New Generation Implants Global New Generation Implants Revenue by Region: 2018-2029
3.3.1 Global New Generation Implants Revenue by Region: 2018-2023
3.3.2 Global New Generation Implants Revenue by Region: 2024-2029
3.4 North America New Generation Implants Market Facts & Figures by Country
3.4.1 North America New Generation Implants Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America New Generation Implants Sales by Country (2018-2029)
3.4.3 North America New Generation Implants Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe New Generation Implants Market Facts & Figures by Country
3.5.1 Europe New Generation Implants Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe New Generation Implants Sales by Country (2018-2029)
3.5.3 Europe New Generation Implants Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific New Generation Implants Market Facts & Figures by Country
3.6.1 Asia Pacific New Generation Implants Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific New Generation Implants Sales by Country (2018-2029)
3.6.3 Asia Pacific New Generation Implants Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America New Generation Implants Market Facts & Figures by Country
3.7.1 Latin America New Generation Implants Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America New Generation Implants Sales by Country (2018-2029)
3.7.3 Latin America New Generation Implants Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa New Generation Implants Market Facts & Figures by Country
3.8.1 Middle East and Africa New Generation Implants Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa New Generation Implants Sales by Country (2018-2029)
3.8.3 Middle East and Africa New Generation Implants Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global New Generation Implants Sales by Type (2018-2029)
4.1.1 Global New Generation Implants Sales by Type (2018-2023)
4.1.2 Global New Generation Implants Sales by Type (2024-2029)
4.1.3 Global New Generation Implants Sales Market Share by Type (2018-2029)
4.2 Global New Generation Implants Revenue by Type (2018-2029)
4.2.1 Global New Generation Implants Revenue by Type (2018-2023)
4.2.2 Global New Generation Implants Revenue by Type (2024-2029)
4.2.3 Global New Generation Implants Revenue Market Share by Type (2018-2029)
4.3 Global New Generation Implants Price by Type (2018-2029)
5 Segment by Application
5.1 Global New Generation Implants Sales by Application (2018-2029)
5.1.1 Global New Generation Implants Sales by Application (2018-2023)
5.1.2 Global New Generation Implants Sales by Application (2024-2029)
5.1.3 Global New Generation Implants Sales Market Share by Application (2018-2029)
5.2 Global New Generation Implants Revenue by Application (2018-2029)
5.2.1 Global New Generation Implants Revenue by Application (2018-2023)
5.2.2 Global New Generation Implants Revenue by Application (2024-2029)
5.2.3 Global New Generation Implants Revenue Market Share by Application (2018-2029)
5.3 Global New Generation Implants Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories New Generation Implants Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Arthrex
6.2.1 Arthrex Corporation Information
6.2.2 Arthrex Description and Business Overview
6.2.3 Arthrex New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Arthrex New Generation Implants Product Portfolio
6.2.5 Arthrex Recent Developments/Updates
6.3 Biotronik SE and Co. KG
6.3.1 Biotronik SE and Co. KG Corporation Information
6.3.2 Biotronik SE and Co. KG Description and Business Overview
6.3.3 Biotronik SE and Co. KG New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biotronik SE and Co. KG New Generation Implants Product Portfolio
6.3.5 Biotronik SE and Co. KG Recent Developments/Updates
6.4 BOSTON SCIENTIFIC CORPORATION
6.4.1 BOSTON SCIENTIFIC CORPORATION Corporation Information
6.4.2 BOSTON SCIENTIFIC CORPORATION Description and Business Overview
6.4.3 BOSTON SCIENTIFIC CORPORATION New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BOSTON SCIENTIFIC CORPORATION New Generation Implants Product Portfolio
6.4.5 BOSTON SCIENTIFIC CORPORATION Recent Developments/Updates
6.5 BD
6.5.1 BD Corporation Information
6.5.2 BD Description and Business Overview
6.5.3 BD New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BD New Generation Implants Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 DANAHER CORPORATION
6.6.1 DANAHER CORPORATION Corporation Information
6.6.2 DANAHER CORPORATION Description and Business Overview
6.6.3 DANAHER CORPORATION New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.6.4 DANAHER CORPORATION New Generation Implants Product Portfolio
6.6.5 DANAHER CORPORATION Recent Developments/Updates
6.7 DENTSPLY SIRNA Inc.
6.6.1 DENTSPLY SIRNA Inc. Corporation Information
6.6.2 DENTSPLY SIRNA Inc. Description and Business Overview
6.6.3 DENTSPLY SIRNA Inc. New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DENTSPLY SIRNA Inc. New Generation Implants Product Portfolio
6.7.5 DENTSPLY SIRNA Inc. Recent Developments/Updates
6.8 Edwards Lifesciences
6.8.1 Edwards Lifesciences Corporation Information
6.8.2 Edwards Lifesciences Description and Business Overview
6.8.3 Edwards Lifesciences New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Edwards Lifesciences New Generation Implants Product Portfolio
6.8.5 Edwards Lifesciences Recent Developments/Updates
6.9 Globus Medical Inc.
6.9.1 Globus Medical Inc. Corporation Information
6.9.2 Globus Medical Inc. Description and Business Overview
6.9.3 Globus Medical Inc. New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Globus Medical Inc. New Generation Implants Product Portfolio
6.9.5 Globus Medical Inc. Recent Developments/Updates
6.10 Integer Holdings Corporation
6.10.1 Integer Holdings Corporation Corporation Information
6.10.2 Integer Holdings Corporation Description and Business Overview
6.10.3 Integer Holdings Corporation New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Integer Holdings Corporation New Generation Implants Product Portfolio
6.10.5 Integer Holdings Corporation Recent Developments/Updates
6.11 Integra LifeSciences Corporation
6.11.1 Integra LifeSciences Corporation Corporation Information
6.11.2 Integra LifeSciences Corporation New Generation Implants Description and Business Overview
6.11.3 Integra LifeSciences Corporation New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Integra LifeSciences Corporation New Generation Implants Product Portfolio
6.11.5 Integra LifeSciences Corporation Recent Developments/Updates
6.12 Institut Straumann AG
6.12.1 Institut Straumann AG Corporation Information
6.12.2 Institut Straumann AG New Generation Implants Description and Business Overview
6.12.3 Institut Straumann AG New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Institut Straumann AG New Generation Implants Product Portfolio
6.12.5 Institut Straumann AG Recent Developments/Updates
6.13 LifeNet Health, Inc.
6.13.1 LifeNet Health, Inc. Corporation Information
6.13.2 LifeNet Health, Inc. New Generation Implants Description and Business Overview
6.13.3 LifeNet Health, Inc. New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.13.4 LifeNet Health, Inc. New Generation Implants Product Portfolio
6.13.5 LifeNet Health, Inc. Recent Developments/Updates
6.14 LivaNova PLC
6.14.1 LivaNova PLC Corporation Information
6.14.2 LivaNova PLC New Generation Implants Description and Business Overview
6.14.3 LivaNova PLC New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.14.4 LivaNova PLC New Generation Implants Product Portfolio
6.14.5 LivaNova PLC Recent Developments/Updates
6.15 Novartis International AG
6.15.1 Novartis International AG Corporation Information
6.15.2 Novartis International AG New Generation Implants Description and Business Overview
6.15.3 Novartis International AG New Generation Implants Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novartis International AG New Generation Implants Product Portfolio
6.15.5 Novartis International AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 New Generation Implants Industry Chain Analysis
7.2 New Generation Implants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 New Generation Implants Production Mode & Process
7.4 New Generation Implants Sales and Marketing
7.4.1 New Generation Implants Sales Channels
7.4.2 New Generation Implants Distributors
7.5 New Generation Implants Customers
8 New Generation Implants Market Dynamics
8.1 New Generation Implants Industry Trends
8.2 New Generation Implants Market Drivers
8.3 New Generation Implants Market Challenges
8.4 New Generation Implants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Laboratories
Arthrex
Biotronik SE and Co. KG
BOSTON SCIENTIFIC CORPORATION
BD
DANAHER CORPORATION
DENTSPLY SIRNA Inc.
Edwards Lifesciences
Globus Medical Inc.
Integer Holdings Corporation
Integra LifeSciences Corporation
Institut Straumann AG
LifeNet Health, Inc.
LivaNova PLC
Novartis International AG

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂